Skip to main content

Table 1 Characteristics of participants

From: Serum klotho: a potential predictor of cerebrovascular disease in hemodialysis patients

  

With

Without

Total

cerebrovascular disease

cerebrovascular disease

(n = 88)

(n = 28)

(n = 60)

Age, years

57 ± 14

66 ± 10

54 ± 14 **

Male, n (%)

56 (63.64%)

20 (71.43%)

36 (60%)

Diabetes history, n (%)

34 (38.64%)

16 (57.14%)

18 (30%)

Hypertension, n (%)

72 (81.82%)

24 (85.71%)

48 (80%)

Tobacco smoking, n (%)

12 (13.64%)

4 (14.29%)

8 (13.33%)

HD vintage (months)

34.55 ± 18.57

40.86 ± 17.09

31.60 ± 18.63

Klotho (pg/ml)

119.10 ± 47.29

91.65 ± 28.19

131.90 ± 49.09**

Hb (g/L)

99.94 ± 15.34

100.93 ± 13.12

99.48 ± 16.36

Ca (mmol/L)

2.19 ± 0.25

2.20 ± 0.23

2.18 ± 0.26

P (mmol/L)

1.90 ± 0.52

1.84 ± 0.56

1.93 ± 0.50

PTH (pg/ml)a

460.23 (185.75–538)

343.32 (185.75–478.5)

514.78 (176.50–727.75)*

SF (ng/ml) a

410.59 (112–528)

349.64 (84.5–404.25)

439.51 (121–582)

Serum iron (umol/L) a

10.99 (8.06–13.30)

10.92 (8.24–12.58)

11.02 (7.71–13.52)

TIBC (umol/L)

47.10 ± 9.16

46.95 ± 9.65

47.18 ± 9.00

Tch (mmol/L)

3.90 ± 0.99

4.05 ± 1.30

3.83 ± 0.79

TG (mmol/L) a

1.51 (0.90–1.80)

1.74 (1.02–1.74)

1.41 (0.85–1.82)

LDL-C (mmol/L)

2.20 ± 0.71

2.32 ± 0.91

2.14 ± 0.59

HDL-C (mmol/L)

0.96 ± 0.30

0.91 ± 0.20

0.98 ± 0.34

ALB (g/L)

40.06 ± 3.56

39.14 ± 3.13

40.44 ± 3.69

  1. Hb hemoglobin, Ca calcium, P phosphate, PTH parathyroid hormone, SF serum ferritin, TIBC Total iron binding capacity, Tch total cholesterol, TG triglycerides, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, ALB albumin
  2. aMedian (25th–75th percentile). *p < 0.05; **p < 0.01